By Sarianne Gruber – As a Harvard Medical School Professor and the Boston Children’s Hospital Chief Innovation Officer, the plights of patients and the hurdles in care are Dr. John Brownstein’s starting points for questions and discovery.
Read More
By Sarianne Gruber – Having been successful for decades maintaining a traditional a product-driven model, pharmaceutical companies are feeling their way toward a new business model: patient-centricity.
By Sarianne Gruber – A Spotlight on Intervention and Analytics with Damian Mingle, Chief Data Scientist, WPC Healthcare. A night at the Gala and 2016 Sepsis Alliance Heroes Awards.
By Sarianne Gruber – A conversation with CEO and founder Dr. Libbe Englander of Pharm3r. They cultivate very large datasets by accessing multiple sources of information on end-user experience of medical products.
By Sarianne Gruber – Hallmarked as a solution to improve healthcare quality, cost and safety, studies are showing health technology is up against a “digital divide” when it comes to patient engagement.
By Sarianne Gruber – “Where ever there are bundled payments today, physicians are typically required to report out on patient-reported outcomes,” says Dr. Todd Johnson, CEO of Noble.MD. Speaker at MedCity Converge in Philadelphia.
By Sarianne Gruber – At the Inforum 2016, I meet Joel Rydbeck and learn how their software and cloud services help their clients advance towards interoperability. A very timely conversation given ONC’s release of two measures addressing ‘widespread interoperability’, as required by MACRA.
A “value-based digital health” reimbursement model as a plausible payment solution for new technology appeared in the 2016 McKinsey Report How Healthcare Systems Can Become Digital-Health Leaders by Gerardo Aue. The concept advocates that since health systems hold the data needed to measure outcomes, why not use this information to measure the outcomes of digital health services?
By Sarianne Gruber – “There are a lot of tech savvy people making apps for tech-savvy people. It’s a wonderful world that we live in with the ability to do that but we are not going to bend the cost curve in the United States by providing an app for an otherwise healthy forty-year-old person with diabetes or for the sixty-year-old that has a heart condition who is out on the golf course.